Children's Hospital Medical Center, Cincinnati
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's Hospital Medical Center, Cincinnati sits in the top decile of US sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count).
Children's Hospital Medical Center, Cincinnati: 571 sponsored US clinical trials, 106 recruiting.
Children's Hospital Medical Center, Cincinnati sponsors 571 registered US clinical trials on ClinicalTrials.gov, 106 of them currently recruiting, and 372 completed. 38 of these trials are in Phase 3-4 (later-stage) and 140 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 13 trials.
Top-decile sponsor footprint
Children's Hospital Medical Center, Cincinnati ranks in the top decile of sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
372 of 412 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
571 total, page 11 of 12
Sodium Supplementation and Growth in Very Low Birth Weight Infants
NCT01795638
Linguistic Characteristics of Suicidal Patients in the Emergency Department
NCT01594138
Development of PK/PD Model for Individualized Propofol Dosing
NCT00948597
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038
Disseminating a Model Intervention to Promote Improved Attention-deficit Hyperactivity Disorder (ADHD) Care in the Community
NCT01056016
Pharmacogenetic Morphine Spine Study
NCT01839461
Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea
NCT01344759
Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
NCT00792233
Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Female Athletes
NCT01034527
Launch II: A Pilot Randomized Control Trial of a Clinic and Clinic Plus Home Intervention for Preschool Obesity
NCT01419951
A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
NCT00890786
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016
An Assessment of Voluntary Adolescent Mental Health Screening and Referral in a Children's Hospital Emergency Department
NCT00750412
Two Anesthetic Techniques in Magnetic Resonance Imaging (MRI)
NCT00894751
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
NCT00792766
CYP2D6 Pharmacogenetics in Risperidone-Treated Children
NCT00783783
A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
NCT00786669
Pharmacokinetics of Levetiracetam (Keppra) in Neonates
NCT01261416
Interacting Together Everyday: Recovery After Childhood Traumatic Brain Injury (TBI) "I-InTERACT
NCT01056146
Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
NCT00598455
Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants
NCT00610688
Behavioral Rx & Nutrition in Pediatric Chronic Disease
NCT01018121
Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD
NCT00631280
Alternate Day Micafungin: A PK Study in Pediatric Patients
NCT00842504
Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial
NCT03007134
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100
NCT00479115
Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine
NCT00671931
Montelukast in Very Low Birthweight Infants
NCT00492102
Internet-Based Treatment for Children With Traumatic Brain Injuries & Their Families: Counselor Assisted Problem Solving
NCT00409448
Role of Placenta Growth Factor in Sickle Acute Chest Syndrome
NCT00448370
Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
NCT00433953
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
NCT00411619
Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease
NCT00530270
A Research Study for Children About Heart Changes and Obstructive Sleep Apnea (OSA)
NCT01837459
Treatment of Depression in Mothers in Home Visitation
NCT01221701
Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma
NCT00395096
Testing Four Feeding Approaches to Oral Feeding in Preterm Infants
NCT02024828
Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01238822
Attention Deficit Disorder Medication Response Study
NCT01727414
Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
NCT00410150
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
NCT00241969
PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
NCT00281619
Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
NCT00272870
Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI
NCT00409058
Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia
NCT00965666
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211
Adolescent Gastric By-pass and Diabetic Precursors
NCT00360373
RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
NCT00457964
CV Disease in Adolescents With Type 2 Diabetes
NCT00114998
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 54 |
| Phase 3 | 15 |
| Phase 4 | 23 |
Therapeutic Areas
What is open in the Children's Hospital Medical Center, Cincinnati pipeline
106 recruiting of 571 indexed (19% open); 372 completed (65%).
Phase mix: 38 late (III/IV) vs 140 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's Hospital Medical Center, Cincinnati: open-pipeline peers nationwide
Peers matched on 571 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 571 trials (± recruiting share)
- National Institute of Neurological Disorders and Stroke (NINDS) · 567 trials · 8% recruiting
- City of Hope Medical Center · 582 trials · 29% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Amgen · 558 trials · 10% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- University of Missouri-Columbia · 19% recruiting · 291 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Montefiore Medical Center · 19% recruiting · 345 trials
Related
What to do with this Children's Hospital Medical Center, Cincinnati page
571 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital Medical Center, Cincinnati or any single study.
- 106 of Children's Hospital Medical Center, Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Children's Hospital Medical Center, Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Children's Hospital Medical Center, Cincinnati pipeline card: 571 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.